Connect with us

Business

CSL (ASX:CSL) share price wobbles on COVID vaccine news – The Motley Fool Australia

The CSL Limited (ASX: CSL) share price is on watch after the UK found “possible links” between the AstraZeneca vaccine and blood clots.

Published

on

Article feature image

The CSL Limited (ASX: CSL) share price is a little wobbly this morning after negative vaccine news overnight from the United Kingdom.
The pharmaceutical giant, which produces and supplies the AstraZeneca PLC (LSE: AZ)COVID-19 vaccine in Australia, is trading close to its opening price after news that the UK medical regulator has found a “possible link” between the vaccine and blood clotting in younger adults. The regulator noted that blood clotting was considered a rare side-effect of the vaccine.

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Broker calls 80% upside on beaten up Appen (ASX:APX) share price
Housing prices outpace the Commonwealth Bank (ASX:CBA) share price